The European Commission (EC) has granted approval to Sanofi's Sarclisa in combination with a regimen of bortezomib, ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...

Dispatch Bio launched with $216 million – backed primarily by Parker Institute for Cancer Immunotherapy, founded by entrepreneur Sean Parker, and ARCH Venture Partners. SAB BIO announced an ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

A soon-to-be-released documentary film aims to change the conversation around hemophilia, a condition in which many female ...

The trial will include patients with non-small cell lung, colorectal, head and neck, and cutaneous cancers with EGFR amplification.

The global Enzyme Replacement Therapy (ERT) market is poised for significant expansion, projected to reach USD 21.62 billion ...

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported second-quarter 2025 adjusted earnings of $5.36 per share, ...

The mercury-based preservative thimerosal will be removed from all flu shots distributed in United States, Health and Human ...

NFL Insider Adam Schefter spoke with The Dallas Express on Wednesday to stress the importance of early screening for type 1 ...